Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium caseinate
- Development stage
- Unknown
- Lead developer
- Nucitec
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
K-Sein is a clinical nutrition product containing calcium caseinate, a protein derived from milk. Developed and marketed by Nucitec in Mexico, K-Sein is used as a dietary supplement to satisfy protein requirements in patients with inadequate daily protein intake due to maldigestion, intestinal malabsorption, malnutrition, or increased protein loss from extensive wounds and burns. It is administered orally or via enteral tube feeding.
- Brand names
- CalseinCasecCaseincalK-SeinSecalbum
- Other names
- calcium caseinatecaseincaseinato de calciokazeina
Beyond the preview
Go deeper on calcium caseinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium caseinate.